Palatin to Report First Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on November 14, 2022
Palatin Technologies, Inc. (NYSE American: PTN) is set to release its first quarter fiscal year 2023 operating results on November 14, 2022, before market open. A conference call will follow at 11:00 a.m. ET for a review of the results and updates on development programs. The press release will be available at 7:30 a.m. ET.
Investors can access the audio webcast through Palatin's website. The company is focused on developing first-in-class medicines for significant unmet medical needs.
- Scheduled release of Q1 FY 2023 results indicates transparency with investors.
- Conference call provides an opportunity for detailed insights into business operations.
- None.
CRANBURY, N.J., Nov. 9, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2023 operating results on Monday, November 14, 2022, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 14, 2022, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
| |
Q1 Fiscal Year 2023 Results Press Release
| 11/14/2022 at 7:30 a.m. ET
|
Q1 Fiscal Year 2023 Conference Call-Live | 11/14/2022 at 11:00 a.m. ET |
US Toll Free Dial-In Number: | 1-866-580-3963 |
International Dial-In Number: | 1-786-697-3501 |
Conference ID:
| 5980994#
|
Q1 Fiscal Year 2023 Conference Call-Replay | 11/14/2022-11/21/2022 |
US Toll Free Dial-In Number: | 1-866-583-1035 |
International Dial-In Number: | +44 (0) 20 8196 1480 |
Replay Passcode:
| 5980994#
|
Audio Webcast Live and Replay Access | http://www.palatin.com |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-first-quarter-fiscal-year-2023-results-teleconference-and-webcast-to-be-held-on-november-14-2022-301673700.html
SOURCE Palatin Technologies, Inc.
FAQ
When will Palatin Technologies report its first quarter fiscal year 2023 results?
What time is the conference call for Palatin's Q1 FY 2023 results?
How can I access the audio webcast for Palatin's Q1 FY 2023 results?